PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
PTEN is often lost in prostate cancer. In this study, the authors show that PTEN can act as a protein phosphatase that targets active PTK6, thereby regulating its oncogenic signaling in prostate cancer progression.
Main Authors: | Darren J. Wozniak, Andre Kajdacsy-Balla, Virgilia Macias, Susan Ball-Kell, Morgan L. Zenner, Wenjun Bie, Angela L. Tyner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01574-5 |
Similar Items
-
Impaired activation of succinate-induced type 2 immunity and secretory cell production in the small intestines of Ptk6−/− male mice
by: Katarina Vlajic, et al.
Published: (2024-10-01) -
Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
by: Luping Qiu, et al.
Published: (2018-01-01) -
Nota Bestari PTK 1 dan PTK 2 ( kompetensi umum ) /
by: 195158 Mohamad Faizal Mansor
Published: (2008) -
PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression
by: Yaw-Dong Lang, et al.
Published: (2019-12-01) -
PTK6 regulates IGF-1-induced anchorage-independent survival.
by: Hanna Y Irie, et al.
Published: (2010-07-01)